4AM DRUGS PRIVATE LIMITED
4AM DRUGS PRIVATE LIMITED is a TELANGANA based PRIVATE LIMITED company, Registered at dated 14-AUG-2020 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of 4AM DRUGS PRIVATE LIMITED is U24297TG2020PTC142806 and registration number is 142806.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC-HYDERABAD India. Authorized share capital of 4AM DRUGS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
4AM DRUGS PRIVATE LIMITED has 2 directors MAGANTI LAKSHMI, BRUNDHA MAGANTI,
The registered Email address of 4AM DRUGS PRIVATE LIMITED is somaraju54@gmail.com and its registered address is FLAT G-A, STILT FLOOR, H.NO.7-1-644/2/1 PLOT 7, SUNDER NAGAR COLONY, SR NAGAR HYDERABAD HYDERABAD TG 500038 IN TELANGANA TELANGANA india 500038.
The current status of 4AM DRUGS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
4AM DRUGS PRIVATE LIMITED
ROC-HYDERABAD
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24297TG2020PTC142806
14-AUG-2020
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
500038
INDIA
FLAT G-A, STILT FLOOR, H.NO.7-1-644/2/1 PLOT 7, SUNDER NAGAR COLONY, SR NAGAR HYDERABAD HYDERABAD TG 500038 IN
somaraju54@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
01715043 | MAGANTI LAKSHMI | Director | 14/08/2020 |
08833798 | BRUNDHA MAGANTI | Director | 14/08/2020 |
Details Updated by Companies
Quick Links
- All Registered company of TELANGANA
- Company Registered in TELANGANA
- All Registered company of HYDERABAD in TELANGANA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.